WG
ABMD

Winton Group’s Abiomed Inc ABMD Stock Holding History

Winton Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,937
Closed -$1.61M – 1510
2021
Q3 		$1.61M Buy
4,937
+2,937
+147% +$995K 0.09% 286
2021
Q2 		$624K Sell
2,000
-1,203
-38% -$369K 0.03% 794
2021
Q1 		$1.02M Buy
3,203
+831
+35% +$266K 0.06% 453
2020
Q4 		$769K Buy
2,372
+34
+1% +$9.4K 0.06% 552
2020
Q3 		$648K Sell
2,338
-11,689
-83% -$3.37M 0.02% 1003
2020
Q2 		$3.39M Buy
14,027
+4,470
+47% +$898K 0.09% 400
2020
Q1 		$1.39M Buy
9,557
+7,255
+315% +$1.2M 0.04% 677
2019
Q4 		$393K Sell
2,302
-22,696
-91% -$4.21M 0.01% 1303
2019
Q3 		$4.45M Buy
24,998
+21,769
+674% +$4.71M 0.05% 354
2019
Q2 		$841K Buy
3,229
+27
+0.8% +$7.16K 0.02% 470
2019
Q1 		$914K Sell
3,202
-863
-21% -$287K 0.02% 365
2018
Q4 		$1.32M Buy
4,065
+559
+16% +$194K 0.03% 318
2018
Q3 		$1.58M Sell
3,506
-29,561
-89% -$11.7M 0.03% 330
2018
Q2 		$13.5M Buy
33,067
+23,999
+265% +$8.69M 0.35% 71
2018
Q1 		$2.64M Buy
+9,068
New +$2.3M 0.07% 289

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Winton Group's ABMD Position: Q4 2021 in Review

Winton Group sold out of Abiomed Inc (ABMD) in Q4 2021, closing a stake of 4,937 shares — an estimated $1.61M sold.

Winton Group first reported a position in ABMD in Q1 2018 and held it in 15 quarters. The position peaked at $13.5M in Q2 2018. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

  • Winton Group reported no remaining Abiomed Inc position as of Q4 2021 after selling out during the quarter.
  • Winton Group sold 4,937 Abiomed Inc shares in Q4 2021, an estimated $1.61M.
  • Winton Group first reported a position in Abiomed Inc in Q1 2018 and held it in 15 quarters.
  • Winton Group's Abiomed Inc position peaked at $13.5M in Q2 2018.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on Winton Group's 13F filing for Q4 2021, filed 10 Feb 2022.